Australia markets closed

Novartis AG (NVSEF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
97.000.00 (0.00%)
At close: 11:34AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 197.57B
Enterprise value 215.16B
Trailing P/E 22.05
Forward P/E 13.40
PEG ratio (5-yr expected) 4.62
Price/sales (ttm)4.22
Price/book (mrq)4.99
Enterprise value/revenue 4.51
Enterprise value/EBITDA 11.74

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 32.34%
S&P500 52-week change 323.57%
52-week high 3109.00
52-week low 390.12
50-day moving average 397.51
200-day moving average 397.96

Share statistics

Avg vol (3-month) 344.48k
Avg vol (10-day) 36.39k
Shares outstanding 52.04B
Implied shares outstanding 62.06B
Float 81.95B
% held by insiders 14.12%
% held by institutions 139.24%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 43.76
Forward annual dividend yield 43.88%
Trailing annual dividend rate 33.92
Trailing annual dividend yield 34.04%
5-year average dividend yield 43.29
Payout ratio 485.32%
Dividend date 308 Mar 2018
Ex-dividend date 407 Mar 2024
Last split factor 21055:1000
Last split date 304 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 31.94%
Operating margin (ttm)30.78%

Management effectiveness

Return on assets (ttm)8.65%
Return on equity (ttm)19.83%

Income statement

Revenue (ttm)47.73B
Revenue per share (ttm)23.17
Quarterly revenue growth (yoy)9.70%
Gross profit (ttm)N/A
EBITDA 18.94B
Net income avi to common (ttm)9.11B
Diluted EPS (ttm)4.40
Quarterly earnings growth (yoy)17.20%

Balance sheet

Total cash (mrq)9.7B
Total cash per share (mrq)4.76
Total debt (mrq)27.28B
Total debt/equity (mrq)68.63%
Current ratio (mrq)0.90
Book value per share (mrq)19.44

Cash flow statement

Operating cash flow (ttm)13.77B
Levered free cash flow (ttm)13.39B